Inhibition of HIV-1 replication in MDMs by flavopiridol

Inhibition of HIV-1 replication in MDMs by flavopiridol

Copyright information:Taken from "Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex"http://www.retrovirology.com/content/4/1/47Retrovirology 2007;4():47-47.Published onli...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Biglione, Sebastian, Byers, Sarah A, Price, Jason P, Nguyen, Van Trung, Bensaude, Olivier, Price, David H, Maury, Wendy
Format: Bild
Sprache:eng
Schlagworte:
Uncategorized
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Biglione, Sebastian
Byers, Sarah A
Price, Jason P
Nguyen, Van Trung
Bensaude, Olivier
Price, David H
Maury, Wendy
description Copyright information:Taken from "Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex"http://www.retrovirology.com/content/4/1/47Retrovirology 2007;4():47-47.Published online 11 Jul 2007PMCID:PMC1948018. MDMs were isolated from healthy donors and infected with HIV-1along with increasing concentrations of flavopiridol. Supernatants were collected at 4, 8, 12 and 16 days post infection. The amount of HIV-1 infection was measured by quantifying the amount of HIV reverse transcriptase enzyme (RT) in the supernatants on the indicated days (BOTTOM graph). Cytotoxicity studies were performed on uninfected MDMs by treating cells with different concentrations of flavopiridol for 4, 8, 12 and 16 days and measuring cell viability by the ATPLite assay. The light readings were normalized to the mock treated cells and plotted (TOP graph). The experiment was performed in MDMs twice and the data from both experiments was pooled, averaged and graphed.
doi_str_mv 10.6084/m9.figshare.18398
format Image
fullrecord <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_18398</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_18398</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_6084_m9_figshare_183983</originalsourceid><addsrcrecordid>eNpjYJA0NNAzM7Aw0c-11EvLTC_OSCxK1TO0MLa04GQw98zLyEzKLMnMz1PIT1Pw8AzTNVQoSi3IyUxOBAtm5in4uvgWKyRVKqTlJJblF2QWZabk5_AwsKYl5hSn8kJpbgZDN9cQZw_dlMSSxOTMktT4gqLM3MSiynhDg3iQ5fG5lvEwy-PBlhuTowcAXM1Ajg</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>image</recordtype></control><display><type>image</type><title>Inhibition of HIV-1 replication in MDMs by flavopiridol</title><source>DataCite</source><creator>Biglione, Sebastian ; Byers, Sarah A ; Price, Jason P ; Nguyen, Van Trung ; Bensaude, Olivier ; Price, David H ; Maury, Wendy</creator><creatorcontrib>Biglione, Sebastian ; Byers, Sarah A ; Price, Jason P ; Nguyen, Van Trung ; Bensaude, Olivier ; Price, David H ; Maury, Wendy</creatorcontrib><description>Copyright information:Taken from "Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex"http://www.retrovirology.com/content/4/1/47Retrovirology 2007;4():47-47.Published online 11 Jul 2007PMCID:PMC1948018. MDMs were isolated from healthy donors and infected with HIV-1along with increasing concentrations of flavopiridol. Supernatants were collected at 4, 8, 12 and 16 days post infection. The amount of HIV-1 infection was measured by quantifying the amount of HIV reverse transcriptase enzyme (RT) in the supernatants on the indicated days (BOTTOM graph). Cytotoxicity studies were performed on uninfected MDMs by treating cells with different concentrations of flavopiridol for 4, 8, 12 and 16 days and measuring cell viability by the ATPLite assay. The light readings were normalized to the mock treated cells and plotted (TOP graph). The experiment was performed in MDMs twice and the data from both experiments was pooled, averaged and graphed.</description><identifier>DOI: 10.6084/m9.figshare.18398</identifier><language>eng</language><publisher>figshare</publisher><subject>Uncategorized</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,1888</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.18398$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Biglione, Sebastian</creatorcontrib><creatorcontrib>Byers, Sarah A</creatorcontrib><creatorcontrib>Price, Jason P</creatorcontrib><creatorcontrib>Nguyen, Van Trung</creatorcontrib><creatorcontrib>Bensaude, Olivier</creatorcontrib><creatorcontrib>Price, David H</creatorcontrib><creatorcontrib>Maury, Wendy</creatorcontrib><title>Inhibition of HIV-1 replication in MDMs by flavopiridol</title><description>Copyright information:Taken from "Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex"http://www.retrovirology.com/content/4/1/47Retrovirology 2007;4():47-47.Published online 11 Jul 2007PMCID:PMC1948018. MDMs were isolated from healthy donors and infected with HIV-1along with increasing concentrations of flavopiridol. Supernatants were collected at 4, 8, 12 and 16 days post infection. The amount of HIV-1 infection was measured by quantifying the amount of HIV reverse transcriptase enzyme (RT) in the supernatants on the indicated days (BOTTOM graph). Cytotoxicity studies were performed on uninfected MDMs by treating cells with different concentrations of flavopiridol for 4, 8, 12 and 16 days and measuring cell viability by the ATPLite assay. The light readings were normalized to the mock treated cells and plotted (TOP graph). The experiment was performed in MDMs twice and the data from both experiments was pooled, averaged and graphed.</description><subject>Uncategorized</subject><fulltext>true</fulltext><rsrctype>image</rsrctype><creationdate>2011</creationdate><recordtype>image</recordtype><sourceid>PQ8</sourceid><recordid>eNpjYJA0NNAzM7Aw0c-11EvLTC_OSCxK1TO0MLa04GQw98zLyEzKLMnMz1PIT1Pw8AzTNVQoSi3IyUxOBAtm5in4uvgWKyRVKqTlJJblF2QWZabk5_AwsKYl5hSn8kJpbgZDN9cQZw_dlMSSxOTMktT4gqLM3MSiynhDg3iQ5fG5lvEwy-PBlhuTowcAXM1Ajg</recordid><startdate>20111230</startdate><enddate>20111230</enddate><creator>Biglione, Sebastian</creator><creator>Byers, Sarah A</creator><creator>Price, Jason P</creator><creator>Nguyen, Van Trung</creator><creator>Bensaude, Olivier</creator><creator>Price, David H</creator><creator>Maury, Wendy</creator><general>figshare</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20111230</creationdate><title>Inhibition of HIV-1 replication in MDMs by flavopiridol</title><author>Biglione, Sebastian ; Byers, Sarah A ; Price, Jason P ; Nguyen, Van Trung ; Bensaude, Olivier ; Price, David H ; Maury, Wendy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_6084_m9_figshare_183983</frbrgroupid><rsrctype>images</rsrctype><prefilter>images</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Uncategorized</topic><toplevel>online_resources</toplevel><creatorcontrib>Biglione, Sebastian</creatorcontrib><creatorcontrib>Byers, Sarah A</creatorcontrib><creatorcontrib>Price, Jason P</creatorcontrib><creatorcontrib>Nguyen, Van Trung</creatorcontrib><creatorcontrib>Bensaude, Olivier</creatorcontrib><creatorcontrib>Price, David H</creatorcontrib><creatorcontrib>Maury, Wendy</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Biglione, Sebastian</au><au>Byers, Sarah A</au><au>Price, Jason P</au><au>Nguyen, Van Trung</au><au>Bensaude, Olivier</au><au>Price, David H</au><au>Maury, Wendy</au><format>book</format><genre>unknown</genre><ristype>GEN</ristype><title>Inhibition of HIV-1 replication in MDMs by flavopiridol</title><date>2011-12-30</date><risdate>2011</risdate><abstract>Copyright information:Taken from "Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex"http://www.retrovirology.com/content/4/1/47Retrovirology 2007;4():47-47.Published online 11 Jul 2007PMCID:PMC1948018. MDMs were isolated from healthy donors and infected with HIV-1along with increasing concentrations of flavopiridol. Supernatants were collected at 4, 8, 12 and 16 days post infection. The amount of HIV-1 infection was measured by quantifying the amount of HIV reverse transcriptase enzyme (RT) in the supernatants on the indicated days (BOTTOM graph). Cytotoxicity studies were performed on uninfected MDMs by treating cells with different concentrations of flavopiridol for 4, 8, 12 and 16 days and measuring cell viability by the ATPLite assay. The light readings were normalized to the mock treated cells and plotted (TOP graph). The experiment was performed in MDMs twice and the data from both experiments was pooled, averaged and graphed.</abstract><pub>figshare</pub><doi>10.6084/m9.figshare.18398</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.6084/m9.figshare.18398
ispartof
issn
language eng
recordid cdi_datacite_primary_10_6084_m9_figshare_18398
source DataCite
subjects Uncategorized
title Inhibition of HIV-1 replication in MDMs by flavopiridol
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T07%3A16%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Biglione,%20Sebastian&rft.date=2011-12-30&rft_id=info:doi/10.6084/m9.figshare.18398&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_18398%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true